Humoral Autoimmune Manifestation in Subacute Thyroiditis
- 1 November 1985
- Vol. 40 (8) , 599-604
- https://doi.org/10.1111/j.1398-9995.1985.tb00889.x
Abstract
To study the autoimmune manifestations in subacute thyroiditis (SAT), the patterns of thyroid antibodies, thyroglobulin and circulating immune complexes were investigated in 10 patients during the course of the disease. Eight patients were thyrotoxic at diagnosis, and became euthyroid during recovery with a median observation of 8 months (4-30 months). Thyroid stimulating immunoglobulins were measured as TSH binding inhibiting immunoglobulins (TBII) and as thyroid stimulating antibodies (TSAb). TBII were present in all patients at least once during the observation period and remained detectable in six patients after recovery. TSAb were detected in three patients without relation to the hyperthyroid state. Thyroglobulin antibodies (TgAb) were present in four patients and persisted in three, while microsomal antibodies (MAb) were negative. Thyroglobulin (Tg) in the TgAb negative patients (n = 6) was high at diagnosis (median 229 .mu.g/l, range 55-375) and fell rapidly during the course of SAT. Circulating immune complexes (CIC), which were found in all patients, reached maximal levels shortly after the onset of the disease and persisted after recovery. No correlation could be demonstrated between the different thyroid antibodies, and there was no clear relation between the levels of CIC and presence of the autoantibodies. However, the changes in CIC paralleled the changes in TBII, and it is suggested that immune complex formation is a major feature of the regulatory mechanisms controlling the immune responses in SAT.Keywords
This publication has 31 references indexed in Scilit:
- Heterogeneity of Autoimmune ThyroiditisAllergy, 1984
- HLA‐D in Hashimoto's thyroiditisTissue Antigens, 1983
- T‐Cell Regulation in Autoimmune ThyroiditisImmunological Reviews, 1981
- CIRCULATING IMMUNE COMPLEXES AND THYROID-STIMULATING IMMUNOGLOBULINS BEFORE, DURING, AND AFTER ANTITHYROID DRUG THERAPY IN PATIENTS WITH GRAVES' DISEASEThe Lancet, 1980
- An improved co-precipitation assay for determination of thyroglobulin antibodiesScandinavian Journal of Clinical and Laboratory Investigation, 1980
- THYROID ADENYLATE CYCLASE STIMULATING IMMUNOGLOBULINS IN THYROID DISEASESClinical Endocrinology, 1979
- Distribution of T-, B-, and thyroglobulin-binding lymphocytes infiltrating the gland in Graves' disease, Hashimoto's thyroiditis, and de Quervain's thyroiditisClinical Immunology and Immunopathology, 1978
- DO THYROID-STIMULATING IMMUNOGLOBULINS CAUSE NON-TOXIC AND TOXIC MULTINODULAR GOITRE?The Lancet, 1978
- POST-PARTUM TRANSIENT THYROTOXICOSIS WITH PAINLESS THYROIDITISThe Lancet, 1977
- Subacute thyroiditisThe American Journal of Medicine, 1971